Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Phase I/II study of decitabine in patients with myelodysplastic syndrome: a multi-center study in Japan.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Phase I/II study of decitabine in patients with myelodysplastic syndrome: a multi-center study in Japan.
Phase I/II study of decitabine in patients with myelodysplastic syndrome: a multi-center study in Japan. Cancer Sci. 2012 Oct; 103(10):1839-47.
View in:
PubMed
subject areas
Aged
Antimetabolites, Antineoplastic
Azacitidine
Dose-Response Relationship, Drug
Female
Humans
Japan
Male
Middle Aged
Myelodysplastic Syndromes
Treatment Outcome